Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP249952.RAMIG05QwE9k4rG6ScYclyYAOt8LjbMOEVasdrt1PJsx0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP249952.RAMIG05QwE9k4rG6ScYclyYAOt8LjbMOEVasdrt1PJsx0130_assertion type Assertion NP249952.RAMIG05QwE9k4rG6ScYclyYAOt8LjbMOEVasdrt1PJsx0130_head.
- NP249952.RAMIG05QwE9k4rG6ScYclyYAOt8LjbMOEVasdrt1PJsx0130_assertion description "[In addition, cervical squamous cell carcinoma and adenocarcinoma have distinct molecular profiles, suggesting that clinical outcomes may be improved with the use of more tailored treatment strategies, including PI3K and MEK inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP249952.RAMIG05QwE9k4rG6ScYclyYAOt8LjbMOEVasdrt1PJsx0130_provenance.
- NP249952.RAMIG05QwE9k4rG6ScYclyYAOt8LjbMOEVasdrt1PJsx0130_assertion evidence source_evidence_literature NP249952.RAMIG05QwE9k4rG6ScYclyYAOt8LjbMOEVasdrt1PJsx0130_provenance.
- NP249952.RAMIG05QwE9k4rG6ScYclyYAOt8LjbMOEVasdrt1PJsx0130_assertion SIO_000772 24037752 NP249952.RAMIG05QwE9k4rG6ScYclyYAOt8LjbMOEVasdrt1PJsx0130_provenance.
- NP249952.RAMIG05QwE9k4rG6ScYclyYAOt8LjbMOEVasdrt1PJsx0130_assertion wasDerivedFrom befree-20140225 NP249952.RAMIG05QwE9k4rG6ScYclyYAOt8LjbMOEVasdrt1PJsx0130_provenance.
- NP249952.RAMIG05QwE9k4rG6ScYclyYAOt8LjbMOEVasdrt1PJsx0130_assertion wasGeneratedBy ECO_0000203 NP249952.RAMIG05QwE9k4rG6ScYclyYAOt8LjbMOEVasdrt1PJsx0130_provenance.